Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo.

Prostate cancer remains a significant concern in my practice, which is why I emphasize the importance of early detection. The American Cancer Society estimates there will be nearly 300,000 new cases ...

The first ever head-to-head comparison of two biomarker tests for grading prostate cancer came out a draw, suggesting that clinicians can use either assessment with confidence, particularly in the ...

A blood test to screen for prostate cancer may be better at doing so than experts originally thought, particularly among Black men, according to a new study. There’s no standard test for prostate ...

THOUSAND MEASLES CASES THIS YEAR. IT’S MEN’S HEALTH MONTH AND IN THE HEADLINES LATELY WITH FORMER PRESIDENT JOE BIDEN’S DIAGNOSIS OF STAGE FOUR PROSTATE CANCER. I SPOKE WITH KOAT HEALTH EXPERT DOCTOR ...

The earliest signs of prostate problems often seem harmless. Experts explain warning symptoms every man should never ignore.

Please provide your email address to receive an email when new articles are posted on . A urine-based test helped reduce unnecessary biopsies among men with prostate cancer. The test appeared to be ...